Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes

A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial

(2021) Richard M Bergenstal et al.   LANCET

Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial

(2020) Sybil A. McAuley et al.   DIABETES CARE

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

(2020) Marc D. Breton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial

(2020) Elvira Isganaitis et al.   Diabetes Technology & Therapeutics

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

One Year Clinical Experience of the First Commercial Hybrid Closed-Loop

(2019) Rayhan A. Lal et al.   DIABETES CARE

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

(2019) Sue A. Brown et al.   NEW ENGLAND JOURNAL OF MEDICINE

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System

(2018) Laurel H. Messer et al.   DIABETES CARE

Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control

(2018) Tonya D. Riddlesworth et al.   Diabetes Technology & Therapeutics

Preserving Skin Integrity with Chronic Device Use in Diabetes

(2018) Laurel H. Messer et al.   Diabetes Technology & Therapeutics

Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review

(2018) C. Farrington   DIABETIC MEDICINE

Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol

(2018) Martin de Bock et al.   BMJ Open

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

(2018) Roy W. Beck et al.   DIABETES CARE

Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes

(2018) Gregory P. Forlenza et al.   Diabetes Technology & Therapeutics

Unknown

(2018)   PEDIATRIC DIABETES

Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials

(2017) Alanna Weisman et al.   Lancet Diabetes & Endocrinology

Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report: Table 1

(2016) David M. Maahs et al.   DIABETES CARE

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

(2016) Richard M. Bergenstal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

(2015) Kellee M. Miller et al.   DIABETES CARE

Auxiliary variables in multiple imputation in regression with missing X: a warning against including too many in small sample research

(2012) Jochen Hardt et al.   BMC Medical Research Methodology

Diabetes-specific emotional distress among adolescents: feasibility, reliability, and validity of the problem areas in diabetes-teen version

(2011) Jill Weissberg-Benchell et al.   PEDIATRIC DIABETES

Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment: Evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial

(2009)   DIABETES CARE